ISPE’s official blog, iSpeak accepts contributions from our Members and professionals in the pharma industry.
In today’s highly regulated pharmaceutical industry, maintaining product quality and patient safety depends on more than systems and procedures. It depends on people. Specifically, it depends on how well individuals understand and apply the principles of a robust pharmaceutical quality system.
As pharmaceutical manufacturing continues its transformation through artificial intelligence (AI), automation, advanced analytics, and increasingly digital operations, one critical factor remains at the center of success: people. While new technologies are reshaping every stage of the product lifecycle, organizations are discovering that sustainable transformation depends not only on...
As the pharmaceutical industry works to reduce its environmental footprint while continuing to deliver life-transforming therapies to patients worldwide, organizations are increasingly seeking solutions that balance operational performance, sustainability, and long-term resilience. Takeda’s AHEAD – Advanced Heat Pump Demonstrator project represents a powerful example of what is possible when...
Emily Heffernan, US Director of New Process Technologies at Arcadis, is a process subject matter expert specializing in biological process and facility design. With more than 20 years of experience, her expertise spans multiple therapeutic areas, including monoclonal antibodies (mAbs), vaccines, cell and gene therapies (C>s), and ribonucleic acid (RNA) therapeutics.
In pharmaceutical manufacturing, product quality begins long before a medicine reaches the production line. Critical utility systems such as pharmaceutical water, pure steam, compressed air, and process gases play a direct role in manufacturing processes and frequently come into contact with products, equipment, and controlled environments. As a result, the quality of these utilities must be...
Turnover package (TOP) is one of the most critical deliverables in pharmaceutical projects. It provides complete documentation on systems, equipment, and components from supplier/service providers to construction and project teams to end users. Traditionally, TOP reviews are performed manually, requiring extensive effort from construction and commissioning and qualification (C&Q) experts...
Sanofi’s Modulus platform is redefining what pharmaceutical manufacturing can look like in an era shaped by personalized medicines, rapidly evolving therapeutic technologies, and increasing global demand for production agility. Recognized with the 2026 ISPE Facility of the Year Awards (FOYA) Innovation – Facility of the Future Category Award, Modulus represents a groundbreaking approach to...
Innovative medicines are advancing across a broad range of therapeutic modalities, from small molecules and biologics to next-generation therapies such as ATMPs, ADCs, radiopharmaceuticals, and mRNA-based products. Yet scientific breakthroughs alone are not enough. Transformative therapies only fulfill their promise when they can be manufactured reliably, scaled efficiently, navigated through...
Bayer AG’s SOLIDA-1 facility in Leverkusen, Germany, has achieved a rare distinction in the pharmaceutical manufacturing industry: winning two categories in the 2026 ISPE Facility of the Year Awards (FOYA). Recognized for both Operations – Operational Excellence and Pharma 4.0™, SOLIDA-1 demonstrates how digital transformation, modular facility design, and autonomous manufacturing can work...
A major takeaway from the 2026 ISPE AI in Life Sciences Summit – Powered by GAMP® which took place in June was the realization that the pharmaceutical industry has reached a turning point in its AI journey. The conversation is no longer about whether organizations should use AI. Instead, the focus has shifted to how AI can be implemented responsibly, how it can create value, and how...
As artificial intelligence (AI), digital transformation, and evolving regulatory expectations continue to reshape the pharmaceutical industry, organizations face a critical challenge: how to innovate while maintaining compliance, quality, and patient safety. The Governance, Risk, and Readiness track at the 2026 ISPE Annual Meeting & Expo, taking place 18–21 October 2026 in Washington,...
Pharmaceutical manufacturers are entering a phase in which AI will no longer be an experimental productivity tool used by a few early adopters. It is becoming a practical work capability for quality, manufacturing, engineering, laboratory, training, and regulatory teams. The challenge is not whether AI can summarize documents, draft investigations, analyze trends, or support inspection...
One of the most anticipated sessions at the 2026 ISPE AI in Life Sciences Summit, Powered by GAMP® was a panel titled, “AI in Pharmaceutical Manufacturing is Outpacing Regulation.” Judging by the attendance, the title struck a chord. The room was full well before the discussion began, and when the session concluded there were still attendees waiting at the microphones and unanswered...
A pattern that has surfaced across the life sciences industry involves AI-assisted workflows generating subtle data or terminology inconsistencies that are not immediately detected by automated validation checks. In regulated environments, these issues are often identified only through experienced human review, and the resulting remediation can be both costly and time intensive. The lesson is...
The ISPE Foundation continues to support the next generation of pharmaceutical professionals through its Professional Development Grant program, providing students and recent graduates with the opportunity to attend global industry events and expand their professional horizons. At the 2026 ISPE Europe Annual Conference in Copenhagen, Denmark, this past April, grant recipients gathered...
The 2026 ISPE International Board of Directors Election provides members with the opportunity to help shape the future of the Society by voting for representatives to fill open seats on the International Board. The Board plays a critical role in establishing ISPE’s vision and mission, setting strategic priorities, and ensuring that operations align with ISPE policies, best practices, and...
One of the great privileges of serving as ISPE’s President and CEO is the opportunity to see our global community in action. Every Affiliate and Chapter has its own character and strengths, but there is something distinctive about the culture of excellence that exists within the ISPE Japan Affiliate.
